New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
11:11 EDTQGEN, MYGN, LH, ILMN, DGX, GHDXPiper sees ASCO positive for Myriad, Genomic, Illumina at Piper Jaffray
Piper Jaffray said it views the American Society of Clinical Oncology conference as positive for Myriad Genetics (MYGN), Genomic Health (GHDX) and Illumina (ILMN), neutral for QIAGEN (QGEN), and neutral-to-negative for Quest Diagnostics (DGX) and LabCorp (LH). Piper notes traffic for Quest and LabCorp booths was lower than Myriad, which it called the "clear winner" among the BRCA test providers.
News For MYGN;GHDX;ILMN;QGEN;DGX;LH From The Last 14 Days
Check below for free stories on MYGN;GHDX;ILMN;QGEN;DGX;LH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
08:04 EDTLHLabCorp, ARCA Biopharma present GENETIC-AF poster at HFSoA meeting
Subscribe for More Information
September 15, 2014
07:21 EDTLHHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 12, 2014
07:51 EDTILMNIllumina management to meet with Leerink
Subscribe for More Information
September 9, 2014
08:05 EDTGHDXGenomic Health to present positive results from nine studies of Oncotype DX
Genomic Health announced that results from nine studies of Oncotype DX in prostate, breast and renal cancers will be presented at the European Society for Medical Oncology, or ESMO, 2014 Congress in Madrid, September 26 30. Included in the program is the first presentation of strongly positive results from an additional large independent clinical validation study of the Oncotype DX prostate cancer test, conducted in collaboration with the Center for Prostate Disease Research, Rockville. This new study demonstrates the test's ability to predict a rise in prostate-specific antigen, or PSA, following surgery and reconfirms Oncotype DX as a predictor of adverse pathology from the biopsy, as previously demonstrated in a published validation study performed by the University of California, San Francisco.
07:11 EDTMYGNMyriad Genetics presented results from myPath Melanoma test clinical study
Subscribe for More Information
September 8, 2014
16:06 EDTDGXQuest Diagnostics: More people testing positive for chikungunya virus in U.S.
Subscribe for More Information
10:06 EDTILMNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AIG (AIG) initiated with a Buy at Citigroup... Agilent (A) initiated with an Equal Weight at Morgan Stanley... Altisource Residential (RESI) initiated with a Neutral at JPMorgan... AngloGold (AU) initiated with an Overweight at JPMorgan... Arista Networks (ANET) initiated with an Outperform at FBN Securities... C1 Financial (BNK) initiated with a Buy at Wunderlich... Cherokee (CHKE) initiated with a Buy at Roth Capital... ContraFect (CFRXU) initiated with a Buy at Maxim... DRDGOLD (DRD) initiated with an Underweight at JPMorgan... Enable Midstream (ENBL) initiated with an Equal Weight at Morgan Stanley... Enservco (ENSV) initiated with an Outperform at Northland... GoPro (GPRO) initiated with an Outperform at FBN Securities... Gold Fields (GFI) initiated with an Overweight at JPMorgan... Gulfport Energy (GPOR) initiated with an Equal Weight at Morgan Stanley... Harmony Gold (HMY) initiated with a Neutral at JPMorgan... Illumina (ILMN) initiated with an Equal Weight at Morgan Stanley... LINN Energy (LINE) reinstated with an Outperform at Credit Suisse... LinnCo (LNCO) reinstated with an Outperform at Credit Suisse... Randgold (GOLD) initiated with a Neutral at JPMorgan... Rentrak (RENT) initiated with a Buy at Needham... Rice Energy (RICE) initiated with an Accumulate at KLR Group... SanDisk (SNDK) initiated with an Outperform at FBN Securities... Seadrill (SDRL) initiated with a Sell at Canaccord... Tesla (TSLA) initiated with an Outperform at FBN Securities... Thermo Fisher (TMO) initiated with an Overweight at Morgan Stanley... Waters (WAT) initiated with an Underweight at Morgan Stanley... Whiting Petroleum (WLL) initiated with an Equal Weight at Morgan Stanley.
08:36 EDTLHARCA Biopharma, LabCorp announce GENETIC-AF poster presentation
Subscribe for More Information
06:08 EDTILMNIllumina initiated with an Equal Weight at Morgan Stanley
Subscribe for More Information
September 3, 2014
16:14 EDTMYGNMyriad Genetics says myRisk test improves detection of cancer-causing mutations
Myriad Genetics announced that the Myriad myRisk Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46% in patients with breast cancer in a new study published in the journal Cancer.
10:00 EDTDGXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:17 EDTDGXQuest Diagnostics upgraded to Conviction Buy from Buy at Goldman
Goldman upgraded Quest Diagnostics to Conviction Buy from Buy based on expectations for improving industry volumes, cost cutting focus, margin expansion potential, and capital allocation. Price target raised to $78 from $66.
September 2, 2014
06:05 EDTQGENFederal prisons to evaluate IGRAs next year, says Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use